Nervous System Lyme Borreliosis Clinical Trial
Official title:
Clinical and Microbiological Parameters in Patients With Early Lyme Neuroborreliosis
NCT number | NCT00910533 |
Other study ID # | LNB-0509 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | January 1, 2009 |
Est. completion date | December 2020 |
The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | December 2020 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years and older |
Eligibility |
Inclusion Criteria: - erythema migrans within 4 months before neurologic involvement and pleocytosis in patients >15 years old Exclusion Criteria: - pregnancy - lactation - history of adverse reaction to a beta-lactam antibiotic |
Country | Name | City | State |
---|---|---|---|
Slovenia | UMC Ljubljana, Department of Infectious Diseases | Ljubljana |
Lead Sponsor | Collaborator |
---|---|
University Medical Centre Ljubljana |
Slovenia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Objective sequelae and post-treatment subjective symptoms in patients treated with ceftriaxone for early Lyme neuroborreliosis | 1 year follow-up | ||
Secondary | Comparison of subjective symptoms between patients treated with ceftriaxone for early Lyme neuroborreliosis and control subjects without a history of Lyme borreliosis | 1 year follow-up |